- Company
- Pharmaceutical industry focuses on Spread of COVID-19 again
- by An, Kyung-Jin May 15, 2020 06:05am
- Pharmaceutical companies are also nervous again as the spread of COVID-19 from Itaewon Club in Seoul. Pharmaceutical companies seem to be cautious about unexpected situations when they tried to earnestly engage in sales marketing activities with the government's distancing in daily life. According to the industry on the 13th, a domestic
- Company
- Sanofi Pasteur GM Baptiste de Clarens to leave Korean office
- by Eo, Yun-Ho May 15, 2020 06:04am
- The General Manager at Sanofi Pasteur Korean office, Baptiste de Clarens is to leave the office at the end of May. According to pharmaceutical industry sources, the resignation of General Manager Baptiste de Clarens has been decided by the headquarter. The decision was apparently made as his term in Korea is ending and a new general manag
- Opinion
- [Reporter's view] ‘Generic exclusivity' must be improved
- by Lee, Tak-Sun May 15, 2020 06:04am
- As the proposed regulation of the co-biological equivalence test was stopped by the Regulatory Reform Committee, The consigned generics business has revived. On the other hand, companies producing single generics that have claimed to regulate co-biological equivalence testing are concerned. They point out that there are many competitors in
- Policy
- Korea takes two-track approach on vaccine and treatment
- by Kim, Jung-Ju May 15, 2020 06:04am
- To speed up the development of Korean-made COVID-19 vaccine and treatment, the Korean government is swiftly working two most urgent regulatory changes. The revised regulation would stipulate Korean Red Cross, a non-healthcare institute, to collect blood samples integral for convalescent plasma therapy, and grant private companies to access biosa
- Policy
- HIRA, promote 'COVID-19' outcome at OECD
- by Lee, Hye-Kyung May 14, 2020 02:21pm
- The meeting of the Working Party on Healthcare Quality and Outcomes (HCQO) of Organisation for Economic Co-operation and Development (OECD) was held on 12 May 2020, chaired by Dr. Sun Min Kim, president of Health Insurance Review and Assessment Service (HIRA) of Korea. OECD HCQO was started in 2001 to develop, collect, and compare a set
- Policy
- Issues on e-cigarette·NDMA were raised again
- by Choi sun May 14, 2020 06:25am
- Issues related to medicines that were quiet due to the COVID-19 outbreak were raised again. There are big issues waiting to be investigated, from sampling investigations of Metformin to conducting work on overseas manufacturing plants and publishing results of risk studies of electronic cigarettes. According to the MFDS on the 13th, it recent
- Company
- Ibrance and Verzenio settle pricing for Faslodex combination
- by Eo, Yun-Ho May 14, 2020 06:24am
- At last, Faslodex plus CDK4/6 inhibitor combination therapy would be accessible as an actual treatment option for patients. According to Korean pharmaceutical industry sources, two cyclin-dependent kinases 4/6 (CDK4/6) inhibitors including Pfizer’s Ibrance (palbociclib) and Lilly's Verzenio (abemaciclib) treating patients with HER2-neg
- Company
- Korean companies to showcase clinical data at ASCO 2020
- by An, Kyung-Jin May 14, 2020 06:24am
- The American Society of Clinical Oncology Annual Meeting (ASCO) 2020 is coming up in a couple of weeks. The 56th ASCO is one of the biggest pharmaceutical and bio industry events along with JP Morgan Healthcare Conference. Every year, about 40,000 pharmaceutical and bio industry and academic representatives are invited to the conference in
- Policy
- Exports of the health industry in April rose 20%
- by Lee, Tak-Sun May 14, 2020 06:24am
- As the export of diagnostic reagents and disinfectants increased in the aftermath of COVID-19, the export amount of the health industry increased by more than 20% from the same period last year. The KHIDI (Korea Health Industry Development institute (Director Kwon Deok-cheol) announced monthly health industry export performance. In April, exp
- Company
- α-GPC has been prescribed more than twice in 3 years
- by Chon, Seung-Hyun May 14, 2020 06:23am
- Sales of Choline alfoscerate, a brain function improving agent, continue to grow. The effectiveness controversy has recently been raised, but the market size has increased by more than 20% this year. Over the past three years, the market size has doubled, exceeding the quarterly prescription size of &8361;100 billion. However, the decline was s
